Related Experiment Video
Updated: May 10, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.1K
Single-cell landscape of undifferentiated pleomorphic sarcoma
Yifei Lu1, Deqian Chen1, Bingnan Wang2
1Department of Pediatric Surgery, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Birth Defects, Shanghai, 201102, China.
Oncogene
|March 8, 2024
Summary
Undifferentiated pleomorphic sarcoma (UPS) exhibits significant intratumor heterogeneity originating from mesenchymal stem cells (MSCs). Targeting epidermal growth factor receptor (EGFR) showed therapeutic potential against this aggressive soft tissue cancer.
Area of Science:
- Oncology
- Genomics
- Cell Biology
Background:
- Undifferentiated pleomorphic sarcoma (UPS) is an aggressive soft tissue tumor with poor prognosis.
- The cellular identity and heterogeneity within UPS tumors remain largely unknown.
- Understanding UPS heterogeneity is crucial for developing effective therapies.
Purpose of the Study:
- To comprehensively characterize the cellular landscape and heterogeneity of Undifferentiated Pleomorphic Sarcoma (UPS).
- To identify potential therapeutic targets within UPS tumors.
- To investigate the role of the tumor microenvironment in UPS progression.
Main Methods:
- Single-cell RNA sequencing of 79,569 individual UPS cells.
- Bioinformatic analysis to identify cell clusters and predict prognostic value.
- Ligand-receptor interaction analysis to map cellular communication.
- In vitro and in vivo studies using patient-derived xenografts and EGFR blockade.
Main Results:
- Eight major cell clusters were identified, revealing UPS originates from mesenchymal stem cells (MSCs) with undifferentiated subclusters.
- Functional heterogeneity in malignant cells and the immune microenvironment was characterized.
- Fused cells expressing monocyte/macrophase markers were detected.
- Abundant cellular interactions involving EGFR and VEGFR were identified.
- Positive EGFR expression (73% of patients) correlated with poor prognosis.
- EGFR blockade with cetuximab inhibited tumor growth in a xenograft model.
Conclusions:
- Transcriptomic analysis provides a detailed map of UPS intratumor heterogeneity.
- Mesenchymal stem cell origin and distinct subclusters contribute to UPS complexity.
- EGFR signaling is a key pathway in UPS, presenting a potential therapeutic target.

